INDIANAPOLIS − If you want an idea of what the Eagles think about tight end Dallas Goedert, you have to go back to 2018 when the Eagles drafted him. Back then, the Eagles had the 32nd and last ...

Methotrexate is a common treatment option for psoriasis. Newer medications are more effective, so methotrexate may be prescribed if other medications have not helped. Methotrexate (MTX ...

Dandruff typically appears as general flaking, but psoriasis develops from a clearly defined plaque (thick patch of skin). Psoriasis plaques can be white or grey and turn pink, red, purple, or dark ...

Generalized pustular psoriasis (GPP) is a serious and rare form of psoriasis that can cause systemic symptoms. Because GPP can be life threatening, hospitalization may be necessary when a flare ...

Please think of them more as approval polls for each player. Goedert missed 3 games and all but 3 snaps in another game early in the season with a hamstring injury. He also went on IR later in the ...

The Eagles didn't need a QB at the time and felt comfortable moving down to No. 52 overall and then bouncing back up to take tight end Dallas Goedert with the 49th pick. And Howie Roseman selected ...

The trial assesses the therapy’s tolerability, pharmacokinetics, and safety in patients with moderate-to-severe plaque psoriasis. Credit: TripleP Studio/Shutterstock. Vyne Therapeutics has dosed the ...

South Dakota State alumni and South Dakota native Dallas Goedert, Carlson's son, recorded two receptions for 27 yards in Philadelphia’s 40-22 win over Kansas City. “To know how devastated he ...

Neiman Marcus is closing its downtown store after more than 100 years in the core of the city. The storied site on Main Street will shutter effective March 31, according to a statement from Saks ...

Bristol Myers Squibb (BMS) has shared positive five-year results from a long-term extension (LTE) study of its oral TYK2 inhibitor Sotyktu (deucravacitinib) in adults with moderate-to-severe plaque ...

Five-year data from the POETYK PSO long-term extension trial confirm the sustained efficacy and safety of Sotyktu (deucravacitinib) for moderate-to-severe plaque psoriasis, with patients maintaining ...